Image de couverture de livre

Guillain‐Barré syndrome: History, pathogenesis, treatment, and future directions

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteur principal:	Richard A. C. Hughes
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	European Journal of Neurology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Guillain‐Barré syndrome: a comprehensive review
par: Roberto Bellanti, et autres
Publié: (2024)

Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome
par: Pieter A. van Doorn, et autres
Publié: (2024)

Pitfalls in Calculating the Incidence of Guillain‐Barre Syndrome During the Pandemic
par: Josef Finsterer
Publié: (2025)

Efgartigimod as Add‐On Treatment in Refractory Guillain–Barré Syndrome: A Case Report
par: Paolo Ripellino, et autres
Publié: (2025)

Efficacy and Safety of Plasmapheresis in Children With Acute Transverse or Flaccid Myelitis, and Guillain‐Barré Syndrome
par: Alix Fleurance, et autres
Publié: (2025)

Brain‐Derived Tau as an Outcome Marker in Guillain‐Barré Syndrome: A Retrospective Cohort Study
par: Brynhildur Hafsteinsdóttir, et autres
Publié: (2025)

Reassessing BD‐Tau as a Prognostic Biomarker in Guillain‐Barré Syndrome: Methodological Considerations for Clinical Interpretation
par: Umar Aziz
Publié: (2025)

Response to Letter to the Editor Regarding “Brain‐Derived Tau as an Outcome Marker in Guillain‐Barré Syndrome: A Retrospective Cohort Study”
par: Brynhildur Hafsteinsdóttir
Publié: (2025)

“Spanish flu,” encephalitis lethargica, and COVID‐19: Progress made, lessons learned, and directions for future research
par: Michael Brainin, et autres
Publié: (2024)

Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein–Barr Virus and Multiple Sclerosis
par: Mario Rodomonti, et autres
Publié: (2025)

Neuroleptic malignant syndrome in Huntington disease
par: Antonio Funcis, et autres
Publié: (2024)

Lessons from the past to understand the future
par: Didier Leys, et autres
Publié: (2024)

Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment
par: Richard Smith, et autres
Publié: (2024)

Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) – A systematic review
par: Jana Kaufmann, et autres
Publié: (2024)

Prevalence and characteristics of visual snow syndrome in a cohort of young Italian adults
par: Marina Romozzi, et autres
Publié: (2024)

Testing the specificity of phenomenological criteria for functional tic‐like behaviours in youth with Tourette syndrome
par: Christelle Nilles, et autres
Publié: (2024)

Cognitive outcomes in Susac syndrome: A 2‐year neuropsychological follow‐up study
par: Tineke Van Vrekhem, et autres
Publié: (2024)

The European Academy of Neurology NeuroCOVID‐19 Task Force: A lesson for the future
par: Francesco Cavallieri, et autres
Publié: (2024)

Rituximab treatment in pediatric‐onset multiple sclerosis
par: Markus Breu, et autres
Publié: (2024)

Deep abdominal breathing reduces heart rate and symptoms during orthostatic challenge in patients with postural orthostatic tachycardia syndrome
par: Moritz Stick, et autres
Publié: (2024)

Enhancing multisensory rehabilitation of visual field defects with transcranial direct current stimulation: A randomized clinical trial
par: Lorenzo Diana, et autres
Publié: (2024)

Neuromuscular ultrasound in combination with nerve conduction studies helps identify inflammatory motor neuropathies from lower motor neuron syndromes
par: Lei Zhang, et autres
Publié: (2024)

Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
par: Nils Erik Gilhus, et autres
Publié: (2024)

Treatment of post‐treatment Lyme disease symptoms—a systematic review
par: Rick Dersch, et autres
Publié: (2024)

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study
par: Susanna Hallberg, et autres
Publié: (2024)

Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis
par: David Reyes‐Leiva, et autres
Publié: (2024)

History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts
par: Angus McNamara, et autres
Publié: (2025)

Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke
par: Alicia Sierra‐Gómez, et autres
Publié: (2024)

In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis
par: Joachim Schuster, et autres
Publié: (2024)

Pharmacological and non‐pharmacological treatments in amyotrophic lateral sclerosis: an Italian real‐world data study
par: Olga Paoletti, et autres
Publié: (2024)

Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study
par: Mikael Cohen, et autres
Publié: (2025)

Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient‐reported outcome measures
par: Bram De Wel, et autres
Publié: (2024)

Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease‐modifying treatment
par: Marijke De Troyer, et autres
Publié: (2024)

Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti‐calcitonin gene‐related peptide therapies: The PREVENAC study
par: Ana Beatriz Gago‐Veiga, et autres
Publié: (2024)

Microembolic signal detection in acute ischemic stroke: Clinical relevance and impact on treatment individualization—A narrative review
par: Eleni Bakola, et autres
Publié: (2024)

Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)
par: Irene Schiavetti, et autres
Publié: (2024)

Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra‐arterial nimodipine might be associated with worse outcomes
par: Serine Ferhat, et autres
Publié: (2024)

Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FTD)
par: Dirk van Paassen, et autres
Publié: (2024)

Potential effects of a mobile stroke unit on time to treatment and outcome in patients treated with thrombectomy or thrombolysis: A Danish–German cross‐border analysis
par: Susanna Bluhm, et autres
Publié: (2024)

Hippocampal Subfield Volume in Relation to Cerebrospinal Fluid Amyloid‐ß in Early Alzheimer's Disease: Diagnostic Utility of 7T MRI
par: Oluwatobi F. Adeyemi, et autres
Publié: (2025)